nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—Platinum-containing Compounds—Carboplatin—testicular cancer	0.42	1	CiPCiCtD
Cisplatin—urinary bladder cancer—testicular cancer	0.101	0.409	CtDrD
Cisplatin—germ cell cancer—testicular cancer	0.077	0.311	CtDrD
Cisplatin—lung cancer—testicular cancer	0.0692	0.28	CtDrD
Cisplatin—SLC31A2—Carboplatin—testicular cancer	0.0244	0.0917	CbGbCtD
Cisplatin—GSTP1—Chlorambucil—testicular cancer	0.0227	0.0852	CbGbCtD
Cisplatin—MT1A—Carboplatin—testicular cancer	0.0177	0.0663	CbGbCtD
Cisplatin—MT2A—Carboplatin—testicular cancer	0.0177	0.0663	CbGbCtD
Cisplatin—ATP7B—Carboplatin—testicular cancer	0.0177	0.0663	CbGbCtD
Cisplatin—ATP7A—Carboplatin—testicular cancer	0.0177	0.0663	CbGbCtD
Cisplatin—SOD1—Carboplatin—testicular cancer	0.014	0.0526	CbGbCtD
Cisplatin—SLC31A1—Carboplatin—testicular cancer	0.014	0.0526	CbGbCtD
Cisplatin—GSTT1—Carboplatin—testicular cancer	0.0117	0.044	CbGbCtD
Cisplatin—GSTM1—Carboplatin—testicular cancer	0.0101	0.0381	CbGbCtD
Cisplatin—ABCC6—Dactinomycin—testicular cancer	0.01	0.0376	CbGbCtD
Cisplatin—GSTT1—Etoposide—testicular cancer	0.00985	0.037	CbGbCtD
Cisplatin—NQO1—Carboplatin—testicular cancer	0.00806	0.0302	CbGbCtD
Cisplatin—GSTP1—Carboplatin—testicular cancer	0.00733	0.0275	CbGbCtD
Cisplatin—ABCC6—Vinblastine—testicular cancer	0.00628	0.0236	CbGbCtD
Cisplatin—GSTP1—Etoposide—testicular cancer	0.00616	0.0231	CbGbCtD
Cisplatin—ABCC6—Etoposide—testicular cancer	0.00566	0.0212	CbGbCtD
Cisplatin—NQO1—Doxorubicin—testicular cancer	0.00461	0.0173	CbGbCtD
Cisplatin—XDH—Carboplatin—testicular cancer	0.00421	0.0158	CbGbCtD
Cisplatin—MPO—Carboplatin—testicular cancer	0.00421	0.0158	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—testicular cancer	0.00386	0.0145	CbGbCtD
Cisplatin—ABCC3—Etoposide—testicular cancer	0.00272	0.0102	CbGbCtD
Cisplatin—XDH—Doxorubicin—testicular cancer	0.00241	0.00905	CbGbCtD
Cisplatin—ABCG2—Dactinomycin—testicular cancer	0.00198	0.00743	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—testicular cancer	0.00185	0.00696	CbGbCtD
Cisplatin—ABCC3—Methotrexate—testicular cancer	0.0018	0.00674	CbGbCtD
Cisplatin—SLC22A2—Vinblastine—testicular cancer	0.00168	0.0063	CbGbCtD
Cisplatin—CYP2B6—Ifosfamide—testicular cancer	0.00164	0.00617	CbGbCtD
Cisplatin—ABCC2—Carboplatin—testicular cancer	0.00147	0.00552	CbGbCtD
Cisplatin—ABCC2—Vinblastine—testicular cancer	0.00137	0.00515	CbGbCtD
Cisplatin—ABCG2—Carboplatin—testicular cancer	0.00133	0.00499	CbGbCtD
Cisplatin—ABCC2—Etoposide—testicular cancer	0.00124	0.00464	CbGbCtD
Cisplatin—PTGS2—Etoposide—testicular cancer	0.00122	0.00458	CbGbCtD
Cisplatin—ABCG2—Etoposide—testicular cancer	0.00112	0.00419	CbGbCtD
Cisplatin—CYP2C9—Ifosfamide—testicular cancer	0.000869	0.00326	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—testicular cancer	0.000843	0.00316	CbGbCtD
Cisplatin—ABCC2—Methotrexate—testicular cancer	0.000817	0.00306	CbGbCtD
Cisplatin—ABCG2—Doxorubicin—testicular cancer	0.000762	0.00286	CbGbCtD
Cisplatin—ABCG2—Methotrexate—testicular cancer	0.000738	0.00277	CbGbCtD
Cisplatin—ABCB1—Dactinomycin—testicular cancer	0.000714	0.00268	CbGbCtD
Cisplatin—SLC31A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000631	0.0715	CbGpPWpGaD
Cisplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—TFAP2C—testicular cancer	0.000588	0.0667	CbGpPWpGaD
Cisplatin—SLC31A2—seminal vesicle—testicular cancer	0.000576	0.0427	CbGeAlD
Cisplatin—GSTT1—Glutathione conjugation—HPGDS—testicular cancer	0.000556	0.063	CbGpPWpGaD
Cisplatin—CYP2B6—Doxorubicin—testicular cancer	0.000536	0.00201	CbGbCtD
Cisplatin—ATP7A—seminal vesicle—testicular cancer	0.000508	0.0376	CbGeAlD
Cisplatin—ABCB1—Vinblastine—testicular cancer	0.000447	0.00168	CbGbCtD
Cisplatin—SOD1—seminal vesicle—testicular cancer	0.000444	0.0329	CbGeAlD
Cisplatin—SLC31A1—seminal vesicle—testicular cancer	0.000433	0.0321	CbGeAlD
Cisplatin—MT2A—gonad—testicular cancer	0.000424	0.0314	CbGeAlD
Cisplatin—ABCC6—Podofilox—Etoposide—testicular cancer	0.000404	0.517	CbGdCrCtD
Cisplatin—ABCB1—Etoposide—testicular cancer	0.000403	0.00151	CbGbCtD
Cisplatin—NQO1—Vincristine—Vinblastine—testicular cancer	0.000378	0.483	CbGdCrCtD
Cisplatin—ATP7B—female gonad—testicular cancer	0.00037	0.0274	CbGeAlD
Cisplatin—MT1A—testis—testicular cancer	0.000367	0.0272	CbGeAlD
Cisplatin—GSTM1—Glutathione conjugation—HPGDS—testicular cancer	0.000358	0.0406	CbGpPWpGaD
Cisplatin—MT2A—female gonad—testicular cancer	0.000344	0.0255	CbGeAlD
Cisplatin—SLC31A2—female gonad—testicular cancer	0.000338	0.0251	CbGeAlD
Cisplatin—ATP7B—testis—testicular cancer	0.000329	0.0243	CbGeAlD
Cisplatin—SLC31A1—gonad—testicular cancer	0.000313	0.0232	CbGeAlD
Cisplatin—GSTM1—gonad—testicular cancer	0.000305	0.0226	CbGeAlD
Cisplatin—MT2A—testis—testicular cancer	0.000305	0.0226	CbGeAlD
Cisplatin—GSTP1—Glutathione conjugation—HPGDS—testicular cancer	0.000305	0.0345	CbGpPWpGaD
Cisplatin—SLC31A2—testis—testicular cancer	0.0003	0.0222	CbGeAlD
Cisplatin—ATP7A—female gonad—testicular cancer	0.000298	0.0221	CbGeAlD
Cisplatin—NQO1—seminal vesicle—testicular cancer	0.000296	0.0219	CbGeAlD
Cisplatin—GSTM1—NRF2 pathway—SLC2A6—testicular cancer	0.000293	0.0332	CbGpPWpGaD
Cisplatin—SLC31A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000287	0.0325	CbGpPWpGaD
Cisplatin—GSTP1—embryo—testicular cancer	0.000282	0.0209	CbGeAlD
Cisplatin—ABCB1—Doxorubicin—testicular cancer	0.000275	0.00103	CbGbCtD
Cisplatin—ABCB1—Methotrexate—testicular cancer	0.000266	0.000999	CbGbCtD
Cisplatin—MT1A—lymph node—testicular cancer	0.000266	0.0197	CbGeAlD
Cisplatin—GSTP1—seminal vesicle—testicular cancer	0.000265	0.0196	CbGeAlD
Cisplatin—ATP7A—testis—testicular cancer	0.000264	0.0196	CbGeAlD
Cisplatin—SOD1—female gonad—testicular cancer	0.000261	0.0193	CbGeAlD
Cisplatin—SLC31A1—female gonad—testicular cancer	0.000254	0.0188	CbGeAlD
Cisplatin—GSTP1—NRF2 pathway—SLC2A6—testicular cancer	0.000249	0.0282	CbGpPWpGaD
Cisplatin—GSTM1—female gonad—testicular cancer	0.000248	0.0184	CbGeAlD
Cisplatin—GSTT1—Phase II conjugation—HPGDS—testicular cancer	0.000247	0.028	CbGpPWpGaD
Cisplatin—NQO1—NRF2 pathway—SLC2A6—testicular cancer	0.000243	0.0275	CbGpPWpGaD
Cisplatin—ATP7B—lymph node—testicular cancer	0.000238	0.0176	CbGeAlD
Cisplatin—SOD1—testis—testicular cancer	0.000231	0.0171	CbGeAlD
Cisplatin—SLC31A1—testis—testicular cancer	0.000226	0.0167	CbGeAlD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000222	0.0252	CbGpPWpGaD
Cisplatin—GSTM1—testis—testicular cancer	0.00022	0.0163	CbGeAlD
Cisplatin—SLC31A2—lymph node—testicular cancer	0.000218	0.0161	CbGeAlD
Cisplatin—ABCC5—NRF2 pathway—SLC2A6—testicular cancer	0.000209	0.0237	CbGpPWpGaD
Cisplatin—ATP7A—lymph node—testicular cancer	0.000192	0.0142	CbGeAlD
Cisplatin—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.000192	0.0217	CbGpPWpGaD
Cisplatin—GSTP1—gonad—testicular cancer	0.000191	0.0142	CbGeAlD
Cisplatin—ABCC5—female gonad—testicular cancer	0.000186	0.0138	CbGeAlD
Cisplatin—CYP4A11—NRF2 pathway—SLC2A6—testicular cancer	0.000181	0.0205	CbGpPWpGaD
Cisplatin—ATP7B—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000179	0.0202	CbGpPWpGaD
Cisplatin—NQO1—female gonad—testicular cancer	0.000174	0.0129	CbGeAlD
Cisplatin—GSTM1—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000173	0.0197	CbGpPWpGaD
Cisplatin—SOD1—lymph node—testicular cancer	0.000168	0.0124	CbGeAlD
Cisplatin—ABCC5—testis—testicular cancer	0.000165	0.0122	CbGeAlD
Cisplatin—SLC31A1—lymph node—testicular cancer	0.000164	0.0121	CbGeAlD
Cisplatin—BCHE—seminal vesicle—testicular cancer	0.00016	0.0119	CbGeAlD
Cisplatin—GSTM1—lymph node—testicular cancer	0.00016	0.0118	CbGeAlD
Cisplatin—GSTM1—Phase II conjugation—HPGDS—testicular cancer	0.000159	0.0181	CbGpPWpGaD
Cisplatin—ABCC3—female gonad—testicular cancer	0.000156	0.0116	CbGeAlD
Cisplatin—GSTP1—female gonad—testicular cancer	0.000155	0.0115	CbGeAlD
Cisplatin—ABCG2—seminal vesicle—testicular cancer	0.000155	0.0115	CbGeAlD
Cisplatin—CYP4A11—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000155	0.0175	CbGpPWpGaD
Cisplatin—NQO1—testis—testicular cancer	0.000154	0.0114	CbGeAlD
Cisplatin—ABCC3—NRF2 pathway—SLC2A6—testicular cancer	0.000154	0.0174	CbGpPWpGaD
Cisplatin—ATP7A—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000152	0.0172	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000148	0.0167	CbGpPWpGaD
Cisplatin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000146	0.0165	CbGpPWpGaD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000146	0.0165	CbGpPWpGaD
Cisplatin—ABCC6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000146	0.0165	CbGpPWpGaD
Cisplatin—GSTT1—Biological oxidations—HPGDS—testicular cancer	0.000145	0.0164	CbGpPWpGaD
Cisplatin—MPO—testis—testicular cancer	0.000142	0.0105	CbGeAlD
Cisplatin—ABCC3—testis—testicular cancer	0.000139	0.0103	CbGeAlD
Cisplatin—GSTP1—testis—testicular cancer	0.000138	0.0102	CbGeAlD
Cisplatin—GSTP1—Phase II conjugation—HPGDS—testicular cancer	0.000136	0.0154	CbGpPWpGaD
Cisplatin—PTGS2—embryo—testicular cancer	0.000132	0.00974	CbGeAlD
Cisplatin—PTGS2—seminal vesicle—testicular cancer	0.000124	0.00915	CbGeAlD
Cisplatin—ABCC2—NRF2 pathway—SLC2A6—testicular cancer	0.000122	0.0138	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000121	0.0137	CbGpPWpGaD
Cisplatin—ABCC5—lymph node—testicular cancer	0.00012	0.00885	CbGeAlD
Cisplatin—NQO1—lymph node—testicular cancer	0.000112	0.00828	CbGeAlD
Cisplatin—GSTM1—C-MYB transcription factor network—KITLG—testicular cancer	0.000111	0.0126	CbGpPWpGaD
Cisplatin—ABCC2—testis—testicular cancer	0.000111	0.0082	CbGeAlD
Cisplatin—CYP2B6—gonad—testicular cancer	0.000103	0.00765	CbGeAlD
Cisplatin—MPO—lymph node—testicular cancer	0.000103	0.00762	CbGeAlD
Cisplatin—MPO—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000103	0.0117	CbGpPWpGaD
Cisplatin—ABCC3—lymph node—testicular cancer	0.0001	0.00744	CbGeAlD
Cisplatin—GSTP1—lymph node—testicular cancer	0.0001	0.0074	CbGeAlD
Cisplatin—MPO—C-MYB transcription factor network—KITLG—testicular cancer	9.46e-05	0.0107	CbGpPWpGaD
Cisplatin—GSTM1—Biological oxidations—HPGDS—testicular cancer	9.33e-05	0.0106	CbGpPWpGaD
Cisplatin—ABCG2—female gonad—testicular cancer	9.1e-05	0.00674	CbGeAlD
Cisplatin—BCHE—testis—testicular cancer	8.35e-05	0.00618	CbGeAlD
Cisplatin—ABCB1—embryo—testicular cancer	8.13e-05	0.00602	CbGeAlD
Cisplatin—ABCG2—testis—testicular cancer	8.07e-05	0.00598	CbGeAlD
Cisplatin—ABCC2—lymph node—testicular cancer	8.02e-05	0.00594	CbGeAlD
Cisplatin—SOD1—AGE/RAGE pathway—MMP2—testicular cancer	7.95e-05	0.00901	CbGpPWpGaD
Cisplatin—GSTP1—Biological oxidations—HPGDS—testicular cancer	7.93e-05	0.00899	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—H2AFZ—testicular cancer	7.83e-05	0.00888	CbGpPWpGaD
Cisplatin—ABCB1—seminal vesicle—testicular cancer	7.64e-05	0.00566	CbGeAlD
Cisplatin—GSTM1—C-MYB transcription factor network—KIT—testicular cancer	7.59e-05	0.0086	CbGpPWpGaD
Cisplatin—CYP2B6—testis—testicular cancer	7.45e-05	0.00551	CbGeAlD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	7.4e-05	0.00839	CbGpPWpGaD
Cisplatin—PTGS2—female gonad—testicular cancer	7.25e-05	0.00537	CbGeAlD
Cisplatin—PTGS2—Arachidonic acid metabolism—HPGDS—testicular cancer	6.92e-05	0.00785	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—SLC2A6—testicular cancer	6.69e-05	0.00758	CbGpPWpGaD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	6.62e-05	0.0075	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—KIT—testicular cancer	6.46e-05	0.00732	CbGpPWpGaD
Cisplatin—BCHE—lymph node—testicular cancer	6.05e-05	0.00448	CbGeAlD
Cisplatin—ABCG2—lymph node—testicular cancer	5.85e-05	0.00433	CbGeAlD
Cisplatin—CYP4A11—Biological oxidations—HPGDS—testicular cancer	5.76e-05	0.00653	CbGpPWpGaD
Cisplatin—ABCB1—gonad—testicular cancer	5.52e-05	0.00409	CbGeAlD
Cisplatin—ABCC3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.93e-05	0.00559	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—MAD1L1—testicular cancer	4.79e-05	0.00543	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—H2AFZ—testicular cancer	4.72e-05	0.00534	CbGpPWpGaD
Cisplatin—PTGS2—lymph node—testicular cancer	4.66e-05	0.00345	CbGeAlD
Cisplatin—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	4.58e-05	0.0052	CbGpPWpGaD
Cisplatin—ABCB1—female gonad—testicular cancer	4.49e-05	0.00332	CbGeAlD
Cisplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	4.23e-05	0.0048	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—H2AFZ—testicular cancer	4.11e-05	0.00466	CbGpPWpGaD
Cisplatin—ABCB1—testis—testicular cancer	3.98e-05	0.00295	CbGeAlD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	3.91e-05	0.00443	CbGpPWpGaD
Cisplatin—MT2A—Immune System—BCL10—testicular cancer	3.5e-05	0.00397	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	3.4e-05	0.00385	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	3.36e-05	0.00381	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—H2AFZ—testicular cancer	3.34e-05	0.00379	CbGpPWpGaD
Cisplatin—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	3.1e-05	0.000722	CcSEcCtD
Cisplatin—Feeling abnormal—Dactinomycin—testicular cancer	3.09e-05	0.00072	CcSEcCtD
Cisplatin—Nausea—Chlorambucil—testicular cancer	3.09e-05	0.000719	CcSEcCtD
Cisplatin—Paraesthesia—Ifosfamide—testicular cancer	3.09e-05	0.000719	CcSEcCtD
Cisplatin—Ill-defined disorder—Etoposide—testicular cancer	3.09e-05	0.000719	CcSEcCtD
Cisplatin—Anaemia—Etoposide—testicular cancer	3.08e-05	0.000717	CcSEcCtD
Cisplatin—PTGS2—C-MYB transcription factor network—KITLG—testicular cancer	3.07e-05	0.00348	CbGpPWpGaD
Cisplatin—Dyspnoea—Ifosfamide—testicular cancer	3.07e-05	0.000714	CcSEcCtD
Cisplatin—Vomiting—Vinblastine—testicular cancer	3.03e-05	0.000706	CcSEcCtD
Cisplatin—Malaise—Etoposide—testicular cancer	3e-05	0.000699	CcSEcCtD
Cisplatin—Breast disorder—Methotrexate—testicular cancer	2.99e-05	0.000697	CcSEcCtD
Cisplatin—Face oedema—Epirubicin—testicular cancer	2.99e-05	0.000697	CcSEcCtD
Cisplatin—Decreased appetite—Ifosfamide—testicular cancer	2.99e-05	0.000696	CcSEcCtD
Cisplatin—Leukopenia—Etoposide—testicular cancer	2.98e-05	0.000694	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Ifosfamide—testicular cancer	2.97e-05	0.000692	CcSEcCtD
Cisplatin—Body temperature increased—Dactinomycin—testicular cancer	2.97e-05	0.000691	CcSEcCtD
Cisplatin—Hypersensitivity—Bleomycin—testicular cancer	2.97e-05	0.000691	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Doxorubicin—testicular cancer	2.96e-05	0.00069	CcSEcCtD
Cisplatin—Pain—Ifosfamide—testicular cancer	2.94e-05	0.000685	CcSEcCtD
Cisplatin—Cerebrovascular accident—Doxorubicin—testicular cancer	2.93e-05	0.000681	CcSEcCtD
Cisplatin—Blood creatinine increased—Epirubicin—testicular cancer	2.9e-05	0.000676	CcSEcCtD
Cisplatin—Asthenia—Bleomycin—testicular cancer	2.89e-05	0.000673	CcSEcCtD
Cisplatin—Convulsion—Etoposide—testicular cancer	2.88e-05	0.000672	CcSEcCtD
Cisplatin—ABCB1—lymph node—testicular cancer	2.88e-05	0.00214	CbGeAlD
Cisplatin—Dehydration—Epirubicin—testicular cancer	2.88e-05	0.000671	CcSEcCtD
Cisplatin—Hyponatraemia—Doxorubicin—testicular cancer	2.88e-05	0.00067	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	2.87e-05	0.000668	CcSEcCtD
Cisplatin—Feeling abnormal—Ifosfamide—testicular cancer	2.84e-05	0.00066	CcSEcCtD
Cisplatin—Nausea—Vinblastine—testicular cancer	2.83e-05	0.000659	CcSEcCtD
Cisplatin—Orthostatic hypotension—Epirubicin—testicular cancer	2.83e-05	0.000659	CcSEcCtD
Cisplatin—Hypokalaemia—Epirubicin—testicular cancer	2.82e-05	0.000657	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	2.82e-05	0.000655	CcSEcCtD
Cisplatin—Pancreatitis—Methotrexate—testicular cancer	2.81e-05	0.000653	CcSEcCtD
Cisplatin—Discomfort—Etoposide—testicular cancer	2.8e-05	0.000652	CcSEcCtD
Cisplatin—Breast disorder—Epirubicin—testicular cancer	2.8e-05	0.000652	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Epirubicin—testicular cancer	2.79e-05	0.00065	CcSEcCtD
Cisplatin—Nasopharyngitis—Epirubicin—testicular cancer	2.77e-05	0.000645	CcSEcCtD
Cisplatin—Face oedema—Doxorubicin—testicular cancer	2.77e-05	0.000645	CcSEcCtD
Cisplatin—Hypersensitivity—Dactinomycin—testicular cancer	2.77e-05	0.000644	CcSEcCtD
Cisplatin—Abdominal discomfort—Methotrexate—testicular cancer	2.74e-05	0.000639	CcSEcCtD
Cisplatin—Body temperature increased—Ifosfamide—testicular cancer	2.72e-05	0.000633	CcSEcCtD
Cisplatin—Pancytopenia—Methotrexate—testicular cancer	2.72e-05	0.000633	CcSEcCtD
Cisplatin—Anaphylactic shock—Etoposide—testicular cancer	2.72e-05	0.000633	CcSEcCtD
Cisplatin—Infection—Etoposide—testicular cancer	2.7e-05	0.000629	CcSEcCtD
Cisplatin—Asthenia—Dactinomycin—testicular cancer	2.69e-05	0.000627	CcSEcCtD
Cisplatin—Blood creatinine increased—Doxorubicin—testicular cancer	2.69e-05	0.000626	CcSEcCtD
Cisplatin—Dehydration—Doxorubicin—testicular cancer	2.67e-05	0.000621	CcSEcCtD
Cisplatin—Thrombocytopenia—Etoposide—testicular cancer	2.66e-05	0.00062	CcSEcCtD
Cisplatin—Tachycardia—Etoposide—testicular cancer	2.65e-05	0.000618	CcSEcCtD
Cisplatin—Skin disorder—Etoposide—testicular cancer	2.64e-05	0.000615	CcSEcCtD
Cisplatin—Hyperhidrosis—Etoposide—testicular cancer	2.63e-05	0.000612	CcSEcCtD
Cisplatin—Pancreatitis—Epirubicin—testicular cancer	2.63e-05	0.000611	CcSEcCtD
Cisplatin—Orthostatic hypotension—Doxorubicin—testicular cancer	2.62e-05	0.00061	CcSEcCtD
Cisplatin—Hypokalaemia—Doxorubicin—testicular cancer	2.61e-05	0.000608	CcSEcCtD
Cisplatin—Breast disorder—Doxorubicin—testicular cancer	2.59e-05	0.000603	CcSEcCtD
Cisplatin—Anorexia—Etoposide—testicular cancer	2.59e-05	0.000603	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	2.58e-05	0.000601	CcSEcCtD
Cisplatin—Diarrhoea—Dactinomycin—testicular cancer	2.57e-05	0.000598	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—testicular cancer	2.56e-05	0.000597	CcSEcCtD
Cisplatin—Vomiting—Bleomycin—testicular cancer	2.56e-05	0.000596	CcSEcCtD
Cisplatin—Pancytopenia—Epirubicin—testicular cancer	2.54e-05	0.000592	CcSEcCtD
Cisplatin—Hypotension—Etoposide—testicular cancer	2.54e-05	0.000591	CcSEcCtD
Cisplatin—Rash—Bleomycin—testicular cancer	2.54e-05	0.000591	CcSEcCtD
Cisplatin—Dermatitis—Bleomycin—testicular cancer	2.54e-05	0.00059	CcSEcCtD
Cisplatin—Hypersensitivity—Ifosfamide—testicular cancer	2.53e-05	0.00059	CcSEcCtD
Cisplatin—Renal failure—Methotrexate—testicular cancer	2.51e-05	0.000584	CcSEcCtD
Cisplatin—Stomatitis—Methotrexate—testicular cancer	2.49e-05	0.000579	CcSEcCtD
Cisplatin—Conjunctivitis—Methotrexate—testicular cancer	2.48e-05	0.000578	CcSEcCtD
Cisplatin—CYP2B6—Biological oxidations—HPGDS—testicular cancer	2.48e-05	0.00281	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—HPGDS—testicular cancer	2.48e-05	0.00281	CbGpPWpGaD
Cisplatin—Asthenia—Ifosfamide—testicular cancer	2.47e-05	0.000575	CcSEcCtD
Cisplatin—Paraesthesia—Etoposide—testicular cancer	2.44e-05	0.000568	CcSEcCtD
Cisplatin—Pancreatitis—Doxorubicin—testicular cancer	2.43e-05	0.000566	CcSEcCtD
Cisplatin—Dyspnoea—Etoposide—testicular cancer	2.42e-05	0.000564	CcSEcCtD
Cisplatin—Hepatobiliary disease—Methotrexate—testicular cancer	2.41e-05	0.000562	CcSEcCtD
Cisplatin—Nausea—Bleomycin—testicular cancer	2.39e-05	0.000557	CcSEcCtD
Cisplatin—Vomiting—Dactinomycin—testicular cancer	2.39e-05	0.000556	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	2.37e-05	0.00269	CbGpPWpGaD
Cisplatin—Rash—Dactinomycin—testicular cancer	2.37e-05	0.000551	CcSEcCtD
Cisplatin—Decreased appetite—Etoposide—testicular cancer	2.36e-05	0.00055	CcSEcCtD
Cisplatin—Diarrhoea—Ifosfamide—testicular cancer	2.35e-05	0.000548	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—testicular cancer	2.35e-05	0.000548	CcSEcCtD
Cisplatin—Renal failure—Epirubicin—testicular cancer	2.35e-05	0.000547	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Etoposide—testicular cancer	2.35e-05	0.000546	CcSEcCtD
Cisplatin—Neuropathy peripheral—Epirubicin—testicular cancer	2.34e-05	0.000545	CcSEcCtD
Cisplatin—Stomatitis—Epirubicin—testicular cancer	2.33e-05	0.000542	CcSEcCtD
Cisplatin—Pain—Etoposide—testicular cancer	2.32e-05	0.000541	CcSEcCtD
Cisplatin—Conjunctivitis—Epirubicin—testicular cancer	2.32e-05	0.000541	CcSEcCtD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	2.29e-05	0.00259	CbGpPWpGaD
Cisplatin—Urinary tract disorder—Methotrexate—testicular cancer	2.26e-05	0.000527	CcSEcCtD
Cisplatin—Hepatobiliary disease—Epirubicin—testicular cancer	2.26e-05	0.000526	CcSEcCtD
Cisplatin—Urethral disorder—Methotrexate—testicular cancer	2.25e-05	0.000523	CcSEcCtD
Cisplatin—Feeling abnormal—Etoposide—testicular cancer	2.24e-05	0.000521	CcSEcCtD
Cisplatin—Nausea—Dactinomycin—testicular cancer	2.23e-05	0.000519	CcSEcCtD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.21e-05	0.00251	CbGpPWpGaD
Cisplatin—Visual impairment—Methotrexate—testicular cancer	2.21e-05	0.000514	CcSEcCtD
Cisplatin—Vomiting—Ifosfamide—testicular cancer	2.19e-05	0.000509	CcSEcCtD
Cisplatin—Bradycardia—Epirubicin—testicular cancer	2.18e-05	0.000508	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—testicular cancer	2.17e-05	0.000506	CcSEcCtD
Cisplatin—Rash—Ifosfamide—testicular cancer	2.17e-05	0.000505	CcSEcCtD
Cisplatin—Dermatitis—Ifosfamide—testicular cancer	2.17e-05	0.000505	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—testicular cancer	2.17e-05	0.000504	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—testicular cancer	2.15e-05	0.000502	CcSEcCtD
Cisplatin—Body temperature increased—Etoposide—testicular cancer	2.15e-05	0.0005	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—testicular cancer	2.15e-05	0.0005	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—testicular cancer	2.14e-05	0.000499	CcSEcCtD
Cisplatin—Tinnitus—Methotrexate—testicular cancer	2.14e-05	0.000497	CcSEcCtD
Cisplatin—Cardiac disorder—Methotrexate—testicular cancer	2.13e-05	0.000495	CcSEcCtD
Cisplatin—Urinary tract disorder—Epirubicin—testicular cancer	2.12e-05	0.000493	CcSEcCtD
Cisplatin—MT2A—Immune System—KITLG—testicular cancer	2.11e-05	0.00239	CbGpPWpGaD
Cisplatin—Connective tissue disorder—Epirubicin—testicular cancer	2.11e-05	0.000491	CcSEcCtD
Cisplatin—Urethral disorder—Epirubicin—testicular cancer	2.1e-05	0.000489	CcSEcCtD
Cisplatin—PTGS2—C-MYB transcription factor network—KIT—testicular cancer	2.1e-05	0.00238	CbGpPWpGaD
Cisplatin—Hepatobiliary disease—Doxorubicin—testicular cancer	2.09e-05	0.000487	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—testicular cancer	2.07e-05	0.000482	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—testicular cancer	2.07e-05	0.000481	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—testicular cancer	2.06e-05	0.000481	CcSEcCtD
Cisplatin—Nausea—Ifosfamide—testicular cancer	2.04e-05	0.000476	CcSEcCtD
Cisplatin—Alopecia—Methotrexate—testicular cancer	2.02e-05	0.000471	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—testicular cancer	2.02e-05	0.00047	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—testicular cancer	2e-05	0.000467	CcSEcCtD
Cisplatin—Hypersensitivity—Etoposide—testicular cancer	2e-05	0.000466	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—testicular cancer	2e-05	0.000465	CcSEcCtD
Cisplatin—Malnutrition—Methotrexate—testicular cancer	1.99e-05	0.000464	CcSEcCtD
Cisplatin—Erythema—Methotrexate—testicular cancer	1.99e-05	0.000464	CcSEcCtD
Cisplatin—Flushing—Epirubicin—testicular cancer	1.99e-05	0.000463	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—testicular cancer	1.99e-05	0.000463	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—testicular cancer	1.96e-05	0.000456	CcSEcCtD
Cisplatin—Asthenia—Etoposide—testicular cancer	1.95e-05	0.000454	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—testicular cancer	1.95e-05	0.000454	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—testicular cancer	1.94e-05	0.000453	CcSEcCtD
Cisplatin—Immune system disorder—Epirubicin—testicular cancer	1.94e-05	0.000451	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—testicular cancer	1.93e-05	0.00045	CcSEcCtD
Cisplatin—Arrhythmia—Epirubicin—testicular cancer	1.92e-05	0.000446	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—testicular cancer	1.91e-05	0.000445	CcSEcCtD
Cisplatin—Alopecia—Epirubicin—testicular cancer	1.89e-05	0.000441	CcSEcCtD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.88e-05	0.00213	CbGpPWpGaD
Cisplatin—Vision blurred—Methotrexate—testicular cancer	1.88e-05	0.000438	CcSEcCtD
Cisplatin—Malnutrition—Epirubicin—testicular cancer	1.87e-05	0.000435	CcSEcCtD
Cisplatin—Erythema—Epirubicin—testicular cancer	1.87e-05	0.000435	CcSEcCtD
Cisplatin—Diarrhoea—Etoposide—testicular cancer	1.86e-05	0.000433	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—testicular cancer	1.85e-05	0.000432	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—testicular cancer	1.85e-05	0.000431	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—testicular cancer	1.85e-05	0.000431	CcSEcCtD
Cisplatin—Anaemia—Methotrexate—testicular cancer	1.84e-05	0.000429	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—testicular cancer	1.84e-05	0.000429	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—testicular cancer	1.84e-05	0.000429	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—testicular cancer	1.84e-05	0.000428	CcSEcCtD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	1.84e-05	0.00208	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—STK11—testicular cancer	1.8e-05	0.00204	CbGpPWpGaD
Cisplatin—Malaise—Methotrexate—testicular cancer	1.8e-05	0.000419	CcSEcCtD
Cisplatin—Muscle spasms—Epirubicin—testicular cancer	1.79e-05	0.000418	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—testicular cancer	1.79e-05	0.000417	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—testicular cancer	1.79e-05	0.000416	CcSEcCtD
Cisplatin—Leukopenia—Methotrexate—testicular cancer	1.79e-05	0.000416	CcSEcCtD
Cisplatin—Arrhythmia—Doxorubicin—testicular cancer	1.77e-05	0.000413	CcSEcCtD
Cisplatin—Vision blurred—Epirubicin—testicular cancer	1.76e-05	0.00041	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—testicular cancer	1.75e-05	0.000408	CcSEcCtD
Cisplatin—Ill-defined disorder—Epirubicin—testicular cancer	1.73e-05	0.000403	CcSEcCtD
Cisplatin—Convulsion—Methotrexate—testicular cancer	1.73e-05	0.000402	CcSEcCtD
Cisplatin—Vomiting—Etoposide—testicular cancer	1.73e-05	0.000402	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—testicular cancer	1.73e-05	0.000402	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—testicular cancer	1.73e-05	0.000402	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—testicular cancer	1.73e-05	0.000402	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	1.72e-05	0.00195	CbGpPWpGaD
Cisplatin—Rash—Etoposide—testicular cancer	1.71e-05	0.000399	CcSEcCtD
Cisplatin—Dermatitis—Etoposide—testicular cancer	1.71e-05	0.000399	CcSEcCtD
Cisplatin—CYP2C9—Biological oxidations—HPGDS—testicular cancer	1.71e-05	0.00193	CbGpPWpGaD
Cisplatin—Flatulence—Doxorubicin—testicular cancer	1.7e-05	0.000396	CcSEcCtD
Cisplatin—Myalgia—Methotrexate—testicular cancer	1.7e-05	0.000395	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	1.69e-05	0.000393	CcSEcCtD
Cisplatin—Malaise—Epirubicin—testicular cancer	1.68e-05	0.000392	CcSEcCtD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	1.68e-05	0.0019	CbGpPWpGaD
Cisplatin—Discomfort—Methotrexate—testicular cancer	1.68e-05	0.000391	CcSEcCtD
Cisplatin—Leukopenia—Epirubicin—testicular cancer	1.67e-05	0.000389	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—testicular cancer	1.66e-05	0.000387	CcSEcCtD
Cisplatin—Anaphylactic shock—Methotrexate—testicular cancer	1.63e-05	0.000379	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—testicular cancer	1.63e-05	0.000379	CcSEcCtD
Cisplatin—Convulsion—Epirubicin—testicular cancer	1.62e-05	0.000377	CcSEcCtD
Cisplatin—Infection—Methotrexate—testicular cancer	1.62e-05	0.000377	CcSEcCtD
Cisplatin—Nausea—Etoposide—testicular cancer	1.61e-05	0.000376	CcSEcCtD
Cisplatin—Ill-defined disorder—Doxorubicin—testicular cancer	1.6e-05	0.000373	CcSEcCtD
Cisplatin—Nervous system disorder—Methotrexate—testicular cancer	1.6e-05	0.000372	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—testicular cancer	1.6e-05	0.000372	CcSEcCtD
Cisplatin—GSTM1—Metabolism—HPGDS—testicular cancer	1.6e-05	0.00181	CbGpPWpGaD
Cisplatin—Thrombocytopenia—Methotrexate—testicular cancer	1.59e-05	0.000371	CcSEcCtD
Cisplatin—Myalgia—Epirubicin—testicular cancer	1.59e-05	0.00037	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—testicular cancer	1.58e-05	0.000369	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—testicular cancer	1.58e-05	0.000368	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	1.58e-05	0.000367	CcSEcCtD
Cisplatin—Hyperhidrosis—Methotrexate—testicular cancer	1.57e-05	0.000366	CcSEcCtD
Cisplatin—Discomfort—Epirubicin—testicular cancer	1.57e-05	0.000366	CcSEcCtD
Cisplatin—MT2A—Immune System—FGFR3—testicular cancer	1.57e-05	0.00178	CbGpPWpGaD
Cisplatin—Malaise—Doxorubicin—testicular cancer	1.56e-05	0.000363	CcSEcCtD
Cisplatin—Anorexia—Methotrexate—testicular cancer	1.55e-05	0.000361	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—testicular cancer	1.55e-05	0.00036	CcSEcCtD
Cisplatin—Oedema—Epirubicin—testicular cancer	1.52e-05	0.000355	CcSEcCtD
Cisplatin—Anaphylactic shock—Epirubicin—testicular cancer	1.52e-05	0.000355	CcSEcCtD
Cisplatin—Hypotension—Methotrexate—testicular cancer	1.52e-05	0.000354	CcSEcCtD
Cisplatin—Infection—Epirubicin—testicular cancer	1.51e-05	0.000352	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—testicular cancer	1.5e-05	0.000348	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—testicular cancer	1.49e-05	0.000348	CcSEcCtD
Cisplatin—Thrombocytopenia—Epirubicin—testicular cancer	1.49e-05	0.000347	CcSEcCtD
Cisplatin—Tachycardia—Epirubicin—testicular cancer	1.49e-05	0.000346	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Methotrexate—testicular cancer	1.48e-05	0.000345	CcSEcCtD
Cisplatin—Skin disorder—Epirubicin—testicular cancer	1.48e-05	0.000345	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—testicular cancer	1.47e-05	0.000343	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—testicular cancer	1.47e-05	0.000342	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—testicular cancer	1.47e-05	0.000341	CcSEcCtD
Cisplatin—Paraesthesia—Methotrexate—testicular cancer	1.46e-05	0.00034	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	1.46e-05	0.00034	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—testicular cancer	1.45e-05	0.000338	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—testicular cancer	1.45e-05	0.000338	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—testicular cancer	1.45e-05	0.000338	CcSEcCtD
Cisplatin—MT2A—Immune System—KIT—testicular cancer	1.44e-05	0.00163	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.44e-05	0.00163	CbGpPWpGaD
Cisplatin—Hypotension—Epirubicin—testicular cancer	1.42e-05	0.000331	CcSEcCtD
Cisplatin—Decreased appetite—Methotrexate—testicular cancer	1.41e-05	0.000329	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—testicular cancer	1.41e-05	0.000328	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—testicular cancer	1.41e-05	0.000328	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Methotrexate—testicular cancer	1.41e-05	0.000327	CcSEcCtD
Cisplatin—Infection—Doxorubicin—testicular cancer	1.4e-05	0.000326	CcSEcCtD
Cisplatin—Pain—Methotrexate—testicular cancer	1.39e-05	0.000324	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Epirubicin—testicular cancer	1.39e-05	0.000323	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—testicular cancer	1.38e-05	0.000322	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—testicular cancer	1.38e-05	0.000321	CcSEcCtD
Cisplatin—Tachycardia—Doxorubicin—testicular cancer	1.38e-05	0.00032	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—testicular cancer	1.37e-05	0.000319	CcSEcCtD
Cisplatin—Paraesthesia—Epirubicin—testicular cancer	1.37e-05	0.000318	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—testicular cancer	1.36e-05	0.000317	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—testicular cancer	1.36e-05	0.000316	CcSEcCtD
Cisplatin—GSTP1—Metabolism—HPGDS—testicular cancer	1.36e-05	0.00154	CbGpPWpGaD
Cisplatin—Anorexia—Doxorubicin—testicular cancer	1.34e-05	0.000313	CcSEcCtD
Cisplatin—Feeling abnormal—Methotrexate—testicular cancer	1.34e-05	0.000312	CcSEcCtD
Cisplatin—Decreased appetite—Epirubicin—testicular cancer	1.32e-05	0.000308	CcSEcCtD
Cisplatin—NQO1—Metabolism—HPGDS—testicular cancer	1.32e-05	0.0015	CbGpPWpGaD
Cisplatin—Hypotension—Doxorubicin—testicular cancer	1.32e-05	0.000307	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Epirubicin—testicular cancer	1.32e-05	0.000306	CcSEcCtD
Cisplatin—Pain—Epirubicin—testicular cancer	1.3e-05	0.000303	CcSEcCtD
Cisplatin—Body temperature increased—Methotrexate—testicular cancer	1.29e-05	0.0003	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	1.28e-05	0.000299	CcSEcCtD
Cisplatin—Paraesthesia—Doxorubicin—testicular cancer	1.27e-05	0.000295	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—testicular cancer	1.26e-05	0.000293	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—testicular cancer	1.26e-05	0.000292	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—testicular cancer	1.23e-05	0.000285	CcSEcCtD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	1.22e-05	0.00138	CbGpPWpGaD
Cisplatin—Gastrointestinal disorder—Doxorubicin—testicular cancer	1.22e-05	0.000283	CcSEcCtD
Cisplatin—Pain—Doxorubicin—testicular cancer	1.21e-05	0.000281	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—testicular cancer	1.2e-05	0.00028	CcSEcCtD
Cisplatin—Hypersensitivity—Methotrexate—testicular cancer	1.2e-05	0.000279	CcSEcCtD
Cisplatin—XDH—Metabolism—HPGDS—testicular cancer	1.19e-05	0.00134	CbGpPWpGaD
Cisplatin—Asthenia—Methotrexate—testicular cancer	1.17e-05	0.000272	CcSEcCtD
Cisplatin—Feeling abnormal—Doxorubicin—testicular cancer	1.16e-05	0.00027	CcSEcCtD
Cisplatin—GSTM1—Metabolism—STK11—testicular cancer	1.16e-05	0.00131	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—HPGDS—testicular cancer	1.14e-05	0.00129	CbGpPWpGaD
Cisplatin—Hypersensitivity—Epirubicin—testicular cancer	1.12e-05	0.000261	CcSEcCtD
Cisplatin—Body temperature increased—Doxorubicin—testicular cancer	1.11e-05	0.000259	CcSEcCtD
Cisplatin—Diarrhoea—Methotrexate—testicular cancer	1.11e-05	0.000259	CcSEcCtD
Cisplatin—Asthenia—Epirubicin—testicular cancer	1.09e-05	0.000254	CcSEcCtD
Cisplatin—Diarrhoea—Epirubicin—testicular cancer	1.04e-05	0.000243	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—testicular cancer	1.04e-05	0.000242	CcSEcCtD
Cisplatin—Vomiting—Methotrexate—testicular cancer	1.03e-05	0.000241	CcSEcCtD
Cisplatin—Rash—Methotrexate—testicular cancer	1.03e-05	0.000239	CcSEcCtD
Cisplatin—Dermatitis—Methotrexate—testicular cancer	1.03e-05	0.000239	CcSEcCtD
Cisplatin—Asthenia—Doxorubicin—testicular cancer	1.01e-05	0.000235	CcSEcCtD
Cisplatin—ABCC5—Disease—H2AFZ—testicular cancer	9.92e-06	0.00112	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	9.89e-06	0.00112	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—STK11—testicular cancer	9.86e-06	0.00112	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—HPGDS—testicular cancer	9.86e-06	0.00112	CbGpPWpGaD
Cisplatin—Vomiting—Epirubicin—testicular cancer	9.69e-06	0.000226	CcSEcCtD
Cisplatin—Nausea—Methotrexate—testicular cancer	9.67e-06	0.000225	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—testicular cancer	9.64e-06	0.000225	CcSEcCtD
Cisplatin—Rash—Epirubicin—testicular cancer	9.6e-06	0.000224	CcSEcCtD
Cisplatin—NQO1—Metabolism—STK11—testicular cancer	9.6e-06	0.00109	CbGpPWpGaD
Cisplatin—Dermatitis—Epirubicin—testicular cancer	9.6e-06	0.000223	CcSEcCtD
Cisplatin—ABCC5—Disease—KITLG—testicular cancer	9.12e-06	0.00103	CbGpPWpGaD
Cisplatin—Nausea—Epirubicin—testicular cancer	9.05e-06	0.000211	CcSEcCtD
Cisplatin—Vomiting—Doxorubicin—testicular cancer	8.96e-06	0.000209	CcSEcCtD
Cisplatin—Rash—Doxorubicin—testicular cancer	8.89e-06	0.000207	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—testicular cancer	8.88e-06	0.000207	CcSEcCtD
Cisplatin—XDH—Metabolism—STK11—testicular cancer	8.61e-06	0.000976	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—HPGDS—testicular cancer	8.38e-06	0.00095	CbGpPWpGaD
Cisplatin—Nausea—Doxorubicin—testicular cancer	8.37e-06	0.000195	CcSEcCtD
Cisplatin—ABCC5—Metabolism—STK11—testicular cancer	8.26e-06	0.000936	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—STK11—testicular cancer	7.16e-06	0.000812	CbGpPWpGaD
Cisplatin—ABCC5—Disease—FGFR3—testicular cancer	6.78e-06	0.000769	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.55e-06	0.000743	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—HPGDS—testicular cancer	6.4e-06	0.000726	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KIT—testicular cancer	6.23e-06	0.000706	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—STK11—testicular cancer	6.09e-06	0.00069	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—HPGDS—testicular cancer	5.78e-06	0.000655	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—HPGDS—testicular cancer	5.72e-06	0.000648	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MMP2—testicular cancer	5.05e-06	0.000572	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—STK11—testicular cancer	4.65e-06	0.000527	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HPGDS—testicular cancer	4.41e-06	0.000499	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HPGDS—testicular cancer	4.24e-06	0.00048	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—STK11—testicular cancer	4.2e-06	0.000476	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—STK11—testicular cancer	4.15e-06	0.000471	CbGpPWpGaD
Cisplatin—PTGS2—Disease—H2AFZ—testicular cancer	3.85e-06	0.000436	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KITLG—testicular cancer	3.54e-06	0.000401	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—STK11—testicular cancer	3.2e-06	0.000363	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HPGDS—testicular cancer	3.12e-06	0.000354	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—STK11—testicular cancer	3.08e-06	0.000349	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HPGDS—testicular cancer	2.92e-06	0.000331	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGFR3—testicular cancer	2.63e-06	0.000298	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KIT—testicular cancer	2.41e-06	0.000274	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—STK11—testicular cancer	2.27e-06	0.000257	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—STK11—testicular cancer	2.12e-06	0.00024	CbGpPWpGaD
